First Human Receives Vision‑Restoring Chip for Stargardt Disease as Firm Sets Sights on Brain‑Computer Interfaces

Science Corporation reported that its experimental vision‑restoring chip has been implanted in a Stargardt‑disease patient, representing the firm’s first application of the device in a human.

An inherited type of macular degeneration, Stargardt disease gradually destroys central vision and can result in legal blindness. At present, treatment is confined to low‑vision aids, creating a significant gap for sight‑restoring therapies.

Created within the firm’s PRIMA program, the implant translates visual data from a tiny camera into electrical impulses that activate surviving retinal cells, enabling the brain to perceive images. Though still early‑stage, the operation shows the system can be surgically installed and switched on without immediate adverse events.

During the recent TechCrunch Disrupt conference, Max Hodak—who previously served as president and co‑founder of Neuralink— described the retinal implant as a proof‑of‑concept for the company’s larger brain‑computer interface (BCI) agenda. He noted that learning to connect external hardware with neural tissue in the eye may guide subsequent attempts to directly couple computers to other brain areas.

Both ophthalmic and neurotechnology experts are monitoring the procedure closely, seeing it as a promising route to regain functional sight for individuals with degenerative retinal diseases. Should later studies verify its safety and effectiveness, the method might be extended to treat age‑related macular degeneration and additional blindness types.

Science Corporation said it plans to start recruiting more subjects for a series of clinical trials designed to collect long‑term information on visual results and device longevity. While regulatory assessment and additional validation remain necessary before commercial rollout, the successful initial operation marks a concrete advance in merging vision restoration with brain‑computer interface technology.